CyberBuild login.asp and browse0.htm cross-site scripting

cyberbuild-multiple-xss (26202) The risk level is classified as MediumMedium Risk

Description:

CyberOffice Warehouse Builder (CyberBuild) is vulnerable to cross-site scripting, caused by improper validation of user-supplied input by login.asp or browse0.htm. A remote attacker could exploit this vulnerability using the 'SessionID' or 'ProductIndex' parameters to execute script in a victim's Web browser within the security context of the hosting Web site, allowing the attacker to steal the victim's cookie-based authentication credentials.


Consequences:

Gain Access

Remedy:

No remedy available as of August 1, 2014.

References:

  • SmartWin Technology Web site: CyberOffice Warehouse Builder (CyberBuild).
  • UNSECURED SYSTEMS 1 may 2006: CyberBuild vuln..
  • BID-17829: CyberBuild Multiple Input Validation Vulnerabilities
  • CVE-2006-2178: Multiple cross-site scripting (XSS) vulnerabilities in CyberBuild allow remote attackers to inject arbitrary web script or HTML via the (1) SessionID parameter to login.asp, (2) ProductIndex parameter to browse0.htm, (3) rowcolor parameter to result.asp, or (4) heading parameter to result.asp. NOTE: vectors 1 and 2 might be resultant from SQL injection.
  • OSVDB ID: 25197: CyberBuild login.asp SessionID Parameter XSS
  • OSVDB ID: 25198: CyberBuild browse0.htm ProductIndex Parameter XSS
  • OSVDB ID: 25199: CyberBuild result.asp Multiple Parameter XSS
  • SA19889: CyberBuild Multiple Vulnerabilities

Platforms Affected:

  • SmartWin Technology CyberBuild

Reported:

May 01, 2006

The information within this database may change without notice. Use of this information constitutes acceptance for use in an AS IS condition. There are NO warranties, implied or otherwise, with regard to this information or its use. Any use of this information is at the user's risk. In no event shall the author/distributor (IBM Internet Security Systems X-Force) be held liable for any damages whatsoever arising out of or in connection with the use or spread of this information.

For corrections or additions please email ignore thisxforceignore this@ignore thisus.ignore thisibm.comignore this

Return to the main page